Central retinal artery occlusion (CRAO) is an ophthalmologic emergency which leads to severe and permanent vision loss. There is no evidence-based therapy for CRAO. The objective of this GION study is to evaluate the efficacy and safety of KUS121 intravitreal (IVT) injection in participants with acute non-arteritic CRAO.

Conditions

  • Central Retinal Artery Occlusion

Intervention

  • KUS121 high dose
  • KUS121 low dose
  • Sham procedure

Principal Investigator

  • Rauser, Michael E

Sponsor

  • Kyoto Drug Discovery & Development Co., Ltd.

*The source of data for this particular study is "ClinicalTrials.gov" and was last updated on 12/23/2024. Loma Linda University does not make any warranties, expressed or implied, with respect to such data, and, furthermore, assumes no liability for any party's use, or the results of such use of the data.

Request Information

Complete the form below to contact the study team and receive more information about this trial.